EMA heads urges greater transparency for clinical drug trials

10/22/2013 | MedCityNews.com

Guido Rasi, executive director of the European Medicines Agency, says that the release of clinical trial data would increase efficiency and cost-effectiveness in drug development, becoming a boon to drug companies rather than creating the loss of competitive advantage they fear. His article, with EMA co-authors, appears in the New England Journal of Medicine. AbbVie and InterMune have filed lawsuits to prevent such data releases.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC